OnRamp

OnRamp Bio, primarily known for its flagship platform ROSALIND, is a bioinformatics company specializing in cloud-based genomic data analysis and interpretation. The company provides a user-friendly interface that allows biologists and researchers to analyze complex multi-omic data, including RNA-seq, single-cell RNA-seq, and ChIP-seq, without requiring advanced programming skills. ROSALIND facilitates real-time collaboration and data sharing, streamlining the transition from raw sequencing data to biological insights. In January 2024, Bruker Corporation acquired a majority stake in the company to integrate its software capabilities into Bruker's multi-omics solutions. The platform is utilized by pharmaceutical companies and academic institutions to accelerate drug discovery and clinical research.